Stockscreener 앱 받기
41.90
0.22%
0.1969
전일 마감가:
$41.70
열려 있는:
$41.71
하루 거래량:
161.03K
Relative Volume:
0.15
시가총액:
$2.55B
수익:
-
순이익/손실:
$-103.69M
주가수익비율:
-22.55
EPS:
-1.8579
순현금흐름:
$-70.46M
1주 성능:
-6.93%
1개월 성능:
+7.62%
6개월 성능:
+119.83%
1년 성능:
+103.75%
1일 변동 폭
$41.20
$42.16
1주일 범위
$40.06
$45.31
52주 변동 폭
$14.79
$48.53
Enliven Therapeutics Inc Stock (ELVN) Company Profile
명칭
Enliven Therapeutics Inc
전화
720-647-8519
주소
6200 LOOKOUT ROAD, BOULDER
Compare ELVN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
41.90 | 2.54B | 0 | -103.69M | -70.46M | -1.8579 |
VRTX
Vertex Pharmaceuticals Inc
|
427.67 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
707.68 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
803.58 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.05 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
299.09 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 개시 | Goldman | Buy |
| 2024-12-13 | 개시 | BTIG Research | Buy |
| 2024-09-09 | 개시 | H.C. Wainwright | Buy |
| 2024-06-11 | 개시 | Robert W. Baird | Outperform |
| 2024-04-09 | 개시 | Mizuho | Buy |
| 2023-03-29 | 개시 | Jefferies | Buy |
모두보기
Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스
Enliven Therapeutics (ELVN) price target increased by 11.14% to 52.02 - MSN
Wall Street Zen Downgrades Enliven Therapeutics (NASDAQ:ELVN) to Sell - MarketBeat
Pictet Asset Management Holding SA Sells 94,852 Shares of Enliven Therapeutics, Inc. $ELVN - MarketBeat
Terns Buyout Deal Ignites Optimism For Enliven Therapeutics’s Blood Cancer Portfolio - MSN
Director sale notice — Enliven Therapeutics (NASDAQ: ELVN) files Form 144 - Stock Titan
[ARS] Enliven Therapeutics, Inc. SEC Filing - Stock Titan
Enliven Therapeutics (NASDAQ: ELVN) seeks larger share authorization - Stock Titan
We're Not Worried About Enliven Therapeutics' (NASDAQ:ELVN) Cash Burn - Sahm
Enliven Therapeutics (NASDAQ:ELVN) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Enliven Therapeutics CMO Helen Collins sells over $238k in stock By Investing.com - Investing.com South Africa
Enliven Therapeutics CMO Helen Collins sells over $238k in stock - Investing.com Australia
Enliven Therapeutics (ELVN) CMO sells 5,000 shares after option exercise - Stock Titan
Trading the Move, Not the Narrative: (ELVN) Edition - Stock Traders Daily
Enliven Therapeutics (ELVN) Stock: Risk Analysis (Slight Loss) 2026-04-20Top Analyst Buy Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Enliven Therapeutics (ELVN) Stock Investment Grade (Smart Money Active) 2026-04-18Crowd Trend Signals - UBND thành phố Hải Phòng
Enliven Therapeutics Stock Surges 194 Percent Amid CML Market Interest - HarianBasis.co
Enliven Therapeutics stock hits 52-week high at $46.83 By Investing.com - Investing.com India
Enliven Therapeutics (ELVN) soars to 5-year high as analysts 'upbeat' - MSN
Enliven Therapeutics (NASDAQ:ELVN) Hits New 1-Year HighTime to Buy? - MarketBeat
Enliven Therapeutics stock hits 52-week high at $46.83 - Investing.com
Enliven Therapeutics (ELVN) Up 194% This Year on Strong CML Market - Insider Monkey
Enliven (ELVN) gets higher price targets from HC Wainwright and Mizuho - MSN
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Short Interest Down 26.3% in March - MarketBeat
Enliven Therapeutics (NASDAQ: ELVN) asks shareholders to approve charter share increase - Stock Titan
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 4.2%What's Next? - MarketBeat
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
ELVN Earnings History & Surprises | EPS & Revenue Results | ENLIVEN THERAPEUTICS INC (NASDAQ:ELVN) - ChartMill
(ELVN) Volatility Zones as Tactical Triggers - Stock Traders Daily
ELVN Surges Amid Strategic Acquisition Talks and Analyst Upgrades - StocksToTrade
H.C. Wainwright reiterates Enliven Therapeutics stock rating on Terns deal details - Investing.com Canada
Merck’s Acquisition Ups Competition in Pharmaceuticals, Enliven Shines - timothysykes.com
Merck’s Acquisition Sparks Surge in Enliven Therapeutics - StocksToTrade
Enliven Therapeutics Regains Attention as Stock Prices Soar - timothysykes.com
Enliven Therapeutics stock hits 52-week high at $40.66 - Investing.com
Enliven Therapeutics stock hits 52-week high at $40.66 By Investing.com - Investing.com South Africa
Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and Mizuho - Insider Monkey
Is Enliven Therapeutics (ELVN) Stock a Buy or Sell | Price at $38.94, Up 0.28%Trending Volume Leaders - Cổng thông tin điện tử Tỉnh Sơn La
5 Best Performing Stocks of Q1 2026 to Watch for Q2 - Insider Monkey
Enliven Therapeutics Inc (ELVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Enliven Therapeutics Inc 주식 (ELVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER |
Apr 17 '26 |
Option Exercise |
2.48 |
5,000 |
12,400 |
30,000 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER |
Apr 17 '26 |
Sale |
47.67 |
5,000 |
238,352 |
25,000 |
0.83%
2.04%
자본화:
|
볼륨(24시간):